Literature DB >> 709039

The relationship between total dose, number of fractions and fractions size in the response of malignant melanoma in patients.

S Hornsey.   

Abstract

The response of melanomas was assessed retrospectively from the clinical notes on 52 patients from three centres in the United Kingdom. The response was very variable. A tentative isoeffect curve was fitted to the UK data which gave a good fit to data from a prospective study from Yale. Clinical data from the Melbourne Clinic on response and fraction size showed a similar response to that from the UK and the combined data showed that the response to fraction sizes of 400-800 rad was significantly better (p about 0.01) than to fraction sizes of 200-299 rad.

Entities:  

Mesh:

Year:  1978        PMID: 709039     DOI: 10.1259/0007-1285-51-611-905

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  5 in total

1.  Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.

Authors:  G Wollensak; L Zografos; C Perret; E Egger; H Fritz-Niggli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  The radiosensitivity of uveal melanoma cells and the cell survival curve.

Authors:  D Soulières; A Rousseau; M Tardif; M Larochelle; M Tremblay; L Vaillancourt; G Pelletier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

3.  Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery.

Authors:  Charles E Rutter; Kimberly L Johung; Xiaopan Yao; Alex Y Lu; Lucia B Jilaveanu; James B Yu; Joseph N Contessa; Harriet M Kluger; Veronica L S Chiang; Ranjit S Bindra
Journal:  J Radiosurg SBRT       Date:  2016

4.  Radiation, heat and anti-melanin drug response of a transformed mouse embryo cell line with varying melanin content.

Authors:  G P Raaphorst; E I Azzam
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

5.  A new melanoma seeker for possible clinical use: selective accumulation of radiolabelled thiouracil.

Authors:  L Dencker; B Larsson; K Olander; S Ullberg
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.